Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 49, 2019 - Issue 4
Submit an article Journal homepage
830
Views
41
CrossRef citations to date
0
Altmetric
Clinical Pharmacokinetics and Metabolism

Characterisation of the absorption, distribution, metabolism, excretion and mass balance of doravirine, a non-nucleoside reverse transcriptase inhibitor in humans

Rosa I. SanchezMerck & Co., Inc., Kenilworth, NJ, USACorrespondence[email protected]
View further author information
,
Kerry L. FillgroveMerck & Co., Inc., Kenilworth, NJ, USAView further author information
,
Ka Lai YeeMerck & Co., Inc., Kenilworth, NJ, USAView further author information
,
Yuexia LiangMerck & Co., Inc., Kenilworth, NJ, USAView further author information
,
Bing LuMerck & Co., Inc., Kenilworth, NJ, USAView further author information
,
Aditya TatavartiMerck & Co., Inc., Kenilworth, NJ, USAView further author information
,
Rachael LiuMerck & Co., Inc., Kenilworth, NJ, USAView further author information
,
Matt S. AndersonMerck & Co., Inc., Kenilworth, NJ, USAView further author information
,
Martin O. BehmMerck & Co., Inc., Kenilworth, NJ, USAView further author information
,
Li FanMerck & Co., Inc., Kenilworth, NJ, USAView further author information
,
Yun LiMerck & Co., Inc., Kenilworth, NJ, USAView further author information
,
Joan R. ButtertonMerck & Co., Inc., Kenilworth, NJ, USAView further author information
,
Marian IwamotoMerck & Co., Inc., Kenilworth, NJ, USAView further author information
&
Sauzanne G. KhaliliehMerck & Co., Inc., Kenilworth, NJ, USAView further author information
 show all
Pages 422-432 | Received 11 Jan 2018, Accepted 08 Mar 2018, Published online: 28 Mar 2018

Citations (41)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yali Wang, Erik De Clercq & Guangdi Li. (2019) Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment. Expert Opinion on Drug Metabolism & Toxicology 15:10, pages 813-829.
Read now

Articles from other publishers (40)

Wenkui Li, Faye Vazvaei‐Smith, Gordon Dear, Jason Boer, Filip Cuyckens, Daniela Fraier, Yuexia Liang, Ding Lu, Heidi Mangus, Patricia Moliner, Mette Lund Pedersen, Andrea A. Romeo, Douglas K. Spracklin, David S. Wagner, Serge Winter & Xiaohui (Sophia) Xu. (2024) Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working Group . Clinical Pharmacology & Therapeutics 115:5, pages 939-953.
Crossref
Paul Thoueille, Luc Delarive, Matthias Cavassini, Thierry Buclin, Laurent A. Decosterd, Catia Marzolini, François R. Girardin & Monia Guidi. (2024) Population pharmacokinetic analysis of doravirine in real‐world people with HIV. British Journal of Clinical Pharmacology 90:4, pages 1058-1065.
Crossref
Reem A. K. Al‐Harbi, Heba A. Emam & Samir Y. Abbas. (2023) Synthesis of new 2‐pyridinone and thiazole derivatives containing coumarin moiety. Journal of Heterocyclic Chemistry 61:1, pages 101-109.
Crossref
Lu Sun, Peng Nie, Li Luan, Piet Herdewijn & Ya-Tao Wang. (2023) Synthetic approaches and application of clinically approved small-molecule Anti-HIV drugs: An update. European Journal of Medicinal Chemistry 261, pages 115847.
Crossref
Yousry A. Ammar, Ahmed Ragab, M. A. Migahed, S. Al-Sharbasy, Mohamed A. Salem, Omnia Karem M. Riad, Heba Mohammed Refat M. Selim, Gehad A. Abd-elmaksoud & Moustafa S. Abusaif. (2023) Design, green synthesis, and quorum sensing quenching potential of novel 2-oxo-pyridines containing a thiophene/furan scaffold and targeting a Las R gene on P. aeruginosa . RSC Advances 13:39, pages 27363-27384.
Crossref
Selbi Keskin. (2023) Design and Synthesis of Novel 1‐((1‐Phenyl‐1 H ‐1,2,3‐triazol‐4‐yl)methyl)pyridin‐2(1 H )‐one Derivatives . ChemistrySelect 8:32.
Crossref
Ghulam Shabir, Aamer Saeed, Wajeeha Zahid, Fatima Naseer, Zainab Riaz, Nafeesa Khalil, Muneeba & Fernando Albericio. (2023) Chemistry and Pharmacology of Fluorinated Drugs Approved by the FDA (2016–2022). Pharmaceuticals 16:8, pages 1162.
Crossref
Hiroyuki Kushida, Dai Watanabe, Hiroki Yagura, Takao Nakauchi, Kazuyuki Hirota, Takashi Ueji, Yasuharu Nishida, Tomoko Uehira, Munehiro Yoshino & Takuma Shirasaka. (2023) Evaluation of plasma doravirine concentrations in patients with HIV-1 undergoing hemodialysis. Journal of Infection and Chemotherapy 29:5, pages 558-561.
Crossref
Abdullah Y. Alzahrani. (2023) Design, synthesis, characterization, and antimicrobial evaluation of some new pyridine and chromene derivatives containing Lidocaine analogue. Journal of Saudi Chemical Society 27:2, pages 101620.
Crossref
Alejandro Morales-Bayuelo & Jesús Sánchez-Márquez. (2023) Receptor-Based Pharmacophore Modelling of a series of ligands used as inhibitors of the SARS-CoV-2 virus by complementary theoretical approaches, molecular docking, and reactivity descriptors.. F1000Research 12, pages 749.
Crossref
Simon G. Wong & Shuguang Ma. 2023. Overcoming Obstacles in Drug Discovery and Development. Overcoming Obstacles in Drug Discovery and Development 137 174 .
Niresh Hariparsad, Diane Ramsden, Kunal Taskar, Justine Badée, Karthik Venkatakrishnan, Micaela B. Reddy, Tamara Cabalu, Dwaipayan Mukherjee, Jessica Rehmel, Jayaprakasam Bolleddula, Arian Emami Riedmaier, Chandra Prakash, Hugues Chanteux, Jialin Mao, Kenichi Umehara, Kushal Shah, Loeckie De Zwart, Martin Dowty, Masakatsu Kotsuma, Mengyao Li, Venkatesh Pilla Reddy, Dermot F. McGinnity & Neil Parrott. (2021) Current Practices, Gap Analysis, and Proposed Workflows for PBPK Modeling of Cytochrome P450 Induction: An Industry Perspective. Clinical Pharmacology & Therapeutics 112:4, pages 770-781.
Crossref
Juan Tiraboschi, Sofia Scévola, Sujan Dilly Penchala, Elisabeth Challenger, Laura Else, Paula Prieto, Maria Saumoy, Arkaitz Imaz, Ana Silva-Klug, Jordi Niubó, Irene Soriano, Saye Khoo, Raul Rigo-Bonin & Daniel Podzamczer. (2022) Total and Unbound Doravirine Concentrations and Viral Suppression in CSF. Clinical Infectious Diseases 74:10, pages 1855-1858.
Crossref
Luis C. Vesga, Camilo A. Ruiz-Hernández, Jeimmy J. Alvarez-Jacome, Jonny E. Duque, Bladimiro Rincon-Orozco & Stelia C. Mendez-Sanchez. (2022) Repurposing of Four Drugs as Anti-SARS-CoV-2 Agents and Their Interactions with Protein Targets. Scientia Pharmaceutica 90:2, pages 24.
Crossref
Guangdi Li, Yali Wang & Erik De Clercq. (2022) Approved HIV reverse transcriptase inhibitors in the past decade. Acta Pharmaceutica Sinica B 12:4, pages 1567-1590.
Crossref
Shibo Lin, Chun Liu, Xiaotian Zhao, Xiao Han, Xuanhao Li, Yongqin Ye & Zheyu Li. (2022) Recent Advances of Pyridinone in Medicinal Chemistry. Frontiers in Chemistry 10.
Crossref
Kelly Bleasby, Robert Houle, Michael Hafey, Meihong Lin, Jingjing Guo, Bing Lu, Rosa I. Sanchez & Kerry L. Fillgrove. (2021) Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major Drug-Metabolizing Enzymes or Transporters. Viruses 13:8, pages 1566.
Crossref
Ana M. Benedicto, Isabel Fuster-Martínez, Joan Tosca, Juan V. Esplugues, Ana Blas-García & Nadezda Apostolova. (2021) NNRTI and Liver Damage: Evidence of Their Association and the Mechanisms Involved. Cells 10:7, pages 1687.
Crossref
Mizuki Kobayashi, Miria Chinen, Atsushi Hirano, Tsunefusa Hayashida, Koji Watanabe & Junichi Masuda. (2021) Successful treatment by doravirine with cobicistat-boosted darunavir for end-stage renal failure under chronic haemodialysis. Journal of Antimicrobial Chemotherapy 76:5, pages 1370-1372.
Crossref
Ka Lai Yee, Tamara D. Cabalu, Yuhsin Kuo, Kerry L. Fillgrove, Yang Liu, Ilias Triantafyllou, Sasha McClain, Daniel Dreyer, Larissa Wenning, S. Aubrey Stoch, Marian Iwamoto, Rosa I. Sanchez & Sauzanne G. Khalilieh. (2020) Physiologically Based Pharmacokinetic Modeling of Doravirine and Its Major Metabolite to Support Dose Adjustment With Rifabutin. The Journal of Clinical Pharmacology 61:3, pages 394-405.
Crossref
Zaikuan J. YuEric P. MosherNamandjé N. Bumpus. (2021) Pharmacogenomics of Antiretroviral Drug Metabolism and Transport. Annual Review of Pharmacology and Toxicology 61:1, pages 565-585.
Crossref
Chao Chen, Xiaodong Hu, Chunxi Wang, Wenxian Lan, Xiaoyu Wu & Chunyang Cao. (2021) Structure- and Mechanism-Based Research Progress of Anti-acquired Immune Deficiency Syndrome Drugs. Chinese Journal of Organic Chemistry 41:8, pages 3015.
Crossref
Edwin Lam, Joseph Schaefer, Richard Zheng, Tingting Zhan & Walter K. Kraft. (2020) Twice‐Daily Doravirine Overcomes the Interaction Effect from Once‐Weekly Rifapentine and Isoniazid in Healthy Volunteers. Clinical and Translational Science 13:6, pages 1244-1250.
Crossref
Ka Lai Yee, Sachin Mittal, Li Fan, Ilias Triantafyllou, Marissa F. Dockendorf, Paul H. Fackler, S. Aubrey Stoch, Sauzanne G. Khalilieh & Marian Iwamoto. (2020) Pharmacokinetics, safety and tolerability of long‐acting parenteral intramuscular injection formulations of doravirine. Journal of Clinical Pharmacy and Therapeutics 45:5, pages 1098-1105.
Crossref
Sauzanne Khalilieh, Ka Lai Yee, Rosa Sanchez, S. Aubrey Stoch, Larissa Wenning & Marian Iwamoto. (2020) Clinical Pharmacokinetics of the Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor Doravirine: An Assessment of the Effect of Patient Characteristics and Drug–Drug Interactions. Clinical Drug Investigation 40:10, pages 927-946.
Crossref
Ka Lai Yee, Adrienne DiBenedetto, Li Fan, Sauzanne Khalilieh, Ilias Triantafyllou, Marie-Helene Vallee, Paul Fackler, S. Aubrey Stoch & Marian Iwamoto. (2020) Comparative Bioavailability of Oral Granule Formulations of the HIV Antiretroviral Drugs Doravirine, Lamivudine, and Tenofovir Disoproxil Fumarate. AAPS PharmSciTech 21:3.
Crossref
Sauzanne Khalilieh, Ka L. Yee, Rosa I. Sanchez, Kate Vaynshteyn, Li Fan, Shawn Searle, Mohammed Bouhajib & Marian Iwamoto. (2019) Evaluation of the Pharmacokinetic Interaction Between Doravirine and Methadone. Clinical Pharmacology in Drug Development 9:2, pages 151-161.
Crossref
Carey Hwang, Ming-Tain Lai & Daria Hazuda. (2019) Rational Design of Doravirine: From Bench to Patients. ACS Infectious Diseases 6:1, pages 64-73.
Crossref
Sarah R. Blevins, E. Kelly Hester, Daniel B. Chastain & David B. Cluck. (2019) Doravirine: A Return of the NNRTI Class?. Annals of Pharmacotherapy 54:1, pages 64-74.
Crossref
Rosa I. Sanchez, Ka Lai Yee, Li Fan, Dawn Cislak, Maureen Martell, Heather R. Jordan, Marian Iwamoto & Sauzanne Khalilieh. (2019) Evaluation of the Pharmacokinetics of Metformin Following Coadministration With Doravirine in Healthy Volunteers. Clinical Pharmacology in Drug Development 9:1, pages 107-114.
Crossref
Wayne Greaves, Hong Wan, Ka Lai Yee, Bhargava Kandala, Pavan Vaddady & Carey Hwang. (2019) Doravirine Exposure and HIV-1 Suppression after Switching from an Efavirenz-Based Regimen to Doravirine-Lamivudine-Tenofovir Disoproxil Fumarate. Antimicrobial Agents and Chemotherapy 63:12.
Crossref
Alison Boyle, Catherine E. Moss, Catia Marzolini & Saye Khoo. (2019) Clinical Pharmacodynamics, Pharmacokinetics, and Drug Interaction Profile of Doravirine. Clinical Pharmacokinetics 58:12, pages 1553-1565.
Crossref
Matt S Anderson, Jocelyn Gilmartin, Li Fan, Ka Lai Yee, Walter K Kraft, Ilias Triantafyllou, Christina Reitmann, Ying Guo, Rachael Liu & Marian Iwamoto. (2018) No Meaningful Drug Interactions with Doravirine, Lamivudine and Tenofovir Disoproxil Fumarate Coadministration. Antiviral Therapy 24:6, pages 443-450.
Crossref
Sauzanne G. Khalilieh, Ka Lai Yee, Rosa I. Sanchez, Li Fan, Kate Vaynshteyn, Kathleen Deschamps, Maureen Martell, Heather R. Jordan & Marian Iwamoto. (2019) A Study to Evaluate Doravirine Pharmacokinetics When Coadministered With Acid‐Reducing Agents. The Journal of Clinical Pharmacology 59:8, pages 1093-1098.
Crossref
Wendy Ankrom, Rosa I. Sanchez, Ka Lai Yee, Li Fan, Pranab Mitra, Dennis Wolford, Ilias Triantafyllou, Laura M. Sterling, S. Aubrey Stoch, Marian Iwamoto & Sauzanne Khalilieh. (2019) Investigation of Pharmacokinetic Interactions between Doravirine and Elbasvir-Grazoprevir and Ledipasvir-Sofosbuvir. Antimicrobial Agents and Chemotherapy 63:5.
Crossref
Sauzanne G. Khalilieh, Ka Lai Yee, Rosa I. Sanchez, Li Fan, Matt S. Anderson, Monali Sura, Tine Laethem, Scott Rasmussen, Luc van Bortel, Griet van Lancker & Marian Iwamoto. (2019) Doravirine and the Potential for CYP3A-Mediated Drug-Drug Interactions. Antimicrobial Agents and Chemotherapy 63:5.
Crossref
Ka Lai Yee, Aziz Ouerdani, Anetta Claussen, Rik de Greef & Larissa Wenning. (2019) Population Pharmacokinetics of Doravirine and Exposure-Response Analysis in Individuals with HIV-1. Antimicrobial Agents and Chemotherapy 63:4.
Crossref
Kelly Bleasby, Kerry L. Fillgrove, Robert Houle, Bing Lu, Jairam Palamanda, Deborah J. Newton, Meihong Lin, Grace Hoyee Chan & Rosa I. Sanchez. (2019) In Vitro Evaluation of the Drug Interaction Potential of Doravirine . Antimicrobial Agents and Chemotherapy 63:4.
Crossref
Kyle John Wilby & Nesma Ahmed Eissa. (2018) Clinical Pharmacokinetics and Drug Interactions of Doravirine. European Journal of Drug Metabolism and Pharmacokinetics 43:6, pages 637-644.
Crossref
Wendy Ankrom, Ka Lai Yee, Rosa I. Sanchez, Adedayo Adedoyin, Li Fan, Thomas Marbury, Richard A. Preston, Marian Iwamoto & Sauzanne G. Khalilieh. (2018) Severe Renal Impairment Has Minimal Impact on Doravirine Pharmacokinetics. Antimicrobial Agents and Chemotherapy 62:8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.